Number of the records: 1  

Peroral IMUNOR, a low-molecular-weight immunomodulator prepared from disintegrated and ultrafiltered leukocytes, enhances recovery from myelosuppression induced by cisplatin or 5-fluorouracil

  1. 1.
    SYSNO ASEP0038982
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JOstatní články
    TitlePeroral IMUNOR, a low-molecular-weight immunomodulator prepared from disintegrated and ultrafiltered leukocytes, enhances recovery from myelosuppression induced by cisplatin or 5-fluorouracil
    TitlePerorální IMUNOR, imunomodulátor s nízkou molekulární hmotností připravený z desintegrovaných a ultrafiltrovaných leukocytů, posiluje úpravu útlumu kostní dřeně indukovaného cisplatinou nebo 5-fluorouracilem
    Author(s) Hofer, Michal (BFU-R) RID, ORCID
    Vacek, Antonín (BFU-R)
    Holá, Jiřina (BFU-R)
    Weiterová, Lenka (BFU-R) RID
    Štreitová, Denisa (BFU-R)
    Source TitleImmunopharmacology and Immunotoxicology - ISSN 0892-3973
    Roč. 28, č. 1 (2006), s. 1-11
    Number of pages11 s.
    Languageeng - English
    CountryUS - United States
    Keywordshematopoiesis ; myelosuppression ; immunomodulator
    Subject RIVBO - Biophysics
    R&D ProjectsKSK5011112 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    CEZAV0Z50040507 - BFU-R (2005-2011)
    AnnotationA single dose of IMUNOR, a low-molecular-weight immunomodulator prepared from disintegrated and ultrafiltered pig leukocytes, was found to enhance recovery of murine pool of hemopoietic progenitor cells for granulocytes and macrophages damaged by a single injection of cytotoxic drugs 5-fluorouracil or cisplatin. The best results were obtained after the treatment with IMUNOR on days 3 or 4 after the injection of 5-fluorouracil or cisplatin. These results together with previous findings obtained in our laboratory suggest that IMUNOR has the potential to become a part of treatment schemes in oncological practice aimed at alleviation of myelosuppression evoked by cytotoxic anti-tumor therapy.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2007
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.